Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results

d, (8) receive required regulatory approvals, (9) successfully conduct clinical trials in a timely manner, (10) establish its competitive position for its products, (11) develop and commercialize products that are superior to existing or newly developed competitor products, (12) develop products without any defects, (13) have sufficient capital resources to fund its operations, (14) protect its intellectual property rights and patents, (15) implement its sales and marketing strategy, (16) successfully attract and retain collaborative partners, (17) successfully commercialize and gain market acceptance for its Keflex products, (18) successfully obtain sufficient manufactured quantities of its drug products at acceptable rates, and (19) retain its senior management and other personnel. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. MiddleBrook undertakes no obligation to update or revise the information in this announcement, whether as a result of new information, future events or circumstances or otherwise.




Three Months Ended Sept 30, Nine Months Ended Sept 30,

2007 2006 2007 2006

Product sales $3,144,532 $2,369,975 $7,598,127 $3,566,563

Costs and


Cost of product

sales 1,183,772 440,159 1,864,643 517,765

Research and

development 5,509,093 5,737,047 18,485,164 19,700,263

Selling, general

and administrative 6,475,742 6,069,529 20,473,947 13,001,312


expenses 13,168,607 12,246,735 40,823,754 33,219,340

Loss from


SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Amada Senior ... opened its newest office in Maryland – its Bethesda location. Amada ... as a project management technology consultant to many of the largest construction firms ...
(Date:10/9/2015)... ... October 09, 2015 , ... BrightStar Care® of ... Cabarrus County Active Living and Parks for its outstanding commitment to volunteering with ... to consistently going above and beyond the call of duty, seniors on the ...
(Date:10/9/2015)... ... October 09, 2015 , ... Dignity Health named Dr. David C. Morro ... – Chandler–McQueen opening later this month. The new facility is licensed under ... West Valley. , “Dr. Morro is an excellent leader and will ensure our ...
(Date:10/9/2015)... ... 2015 , ... When the producers of the popular ‘Ask This Old House’ ... Hollywood, CA, they turned to a trusted resource in Tamarack Technologies. , “Our HV ... because of our successful past experience with the show they enlisted our help,” said ...
(Date:10/9/2015)... ... , ... Bag Tags Inc. will provide custom bag tags, ... the annual IRONMAN World Championship in Kailua-Kona, Hawaii, this Saturday, October 10. ... place in Hawaii every year since 1978. , As part of its ongoing ...
Breaking Medicine News(10 mins):
... , LOS ANGELES, Oct. 9 Torrid,s 2009 House of ... for the retailer known as the destination for young women,s ... the courtyard at the Fashion Institute of Design and Merchandising ... who work to motivate women and to support the National ...
... cancer epidemic, researchers say , FRIDAY, Oct. 9 (HealthDay News) ... increase in cases of a rare type of head and ... -- a tumor that grows behind the nose and at ... about one of every 100,000 people in the United States. ...
... of Hematology (ASH) is proud to announce the ... which builds hematologic capacity in developing countries. Through ... countries receive valuable clinical, laboratory, or technological training ... under the mentorship of an ASH member anywhere ...
... ... as CMS-mandated Home Health Agency Satisfaction Reporting Set to Begin , , ... South Bend, IN (Vocus) October ... country, and a new report released today finds an upward trend in overall home ...
... fight treatment-related bone loss, researchers say , FRIDAY, Oct. 9 ... of vitamin D, which could lead to weaker bones and ... doses of vitamin D for them. , "Vitamin D is ... have accelerated bone loss due to the nature of hormone ...
... ... 19, 2009 in San Diego, CA., , ... Horsham, PA (Vocus) October 8, 2009 -- The Drug Information Association (DIA) ... 2009 in San Diego, CA., , , , ,Electronic CTD is poised to become the ...
Cached Medicine News:
(Date:10/9/2015)... , October 9, 2015 ... --> The report summarizes key ... overall status of the manufacturers making ... and direction for companies and individuals ... . --> ...
(Date:10/9/2015)... 9, 2015 Henry Schein , Inc. ... health care products and services to office-based dental, animal ... the Henry Schein Disaster Relief Hotline is open for ... financial issues as a result of the disastrous flooding ... number for all Henry Schein customers is ...
(Date:10/9/2015)... , Oct. 9, 2015   Lexicon Pharmaceuticals, Inc. ... TELESTAR Phase 3 clinical study of telotristat etiprate has been ... annual symposium to be held from October 15-17, in ... with patients who completed the randomized treatment portion of the ... a poster session. --> --> ...
Breaking Medicine Technology:
... WIRE)--Apr 26, 2007 - A new study ... of Child Neurology indicates,that a treatment from ... cerebral palsy improves their quality of life ... The findings of this Medtronic-sponsored study should,expand ...
... Effectiveness of Hypertension,Treatment Valsartan in Preventing Cardiovascular ... /Xinhua-PRNewswire/ -- The clinical,outcomes of the JIKEI ... the Jikei University School of Medicine, was ... The,Lancet. The study, involving more than 3,000 ...
Cached Medicine Technology:
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag....
Silicone Flat Hubless Drains...
Bard® Channel Drain...
Used to negotiate spiral folds of the cystic duct and the lumen of the common duct. TFE coating reduces surface tension. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: